Q BioMed (QBIO) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free QBIO Stock Alerts $0.0002 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Q BioMed Short Interest DataCurrent Short Volume8,100 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$20.25Short Interest Ratio / Days to Cover0.1Last Record DateJune 30, 2023Outstanding Shares145,095,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume0 sharesAverage Trading Volume538 sharesToday's Volume Vs. Average0% Short Selling Q BioMed ? Sign up to receive the latest short interest report for Q BioMed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatQBIO Short Interest Over TimeQBIO Days to Cover Over TimeQBIO Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Q BioMed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20238,100 shares $20.25 No ChangeN/A0.1 $0.00 5/31/20239,600 shares $115.20 -58.1%N/A0 $0.01 5/15/202322,900 shares $274.80 +118.1%N/A0 $0.01 4/30/202310,500 shares $127.05 -41.7%N/A0 $0.01 4/15/202318,000 shares $276.30 No ChangeN/A0 $0.02 3/15/202348,000 shares $667.20 +1,746.2%N/A0 $0.01 Get the Latest News and Ratings for QBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Q BioMed and its competitors with MarketBeat's FREE daily newsletter. 2/28/20232,600 shares $31.20 -93.1%N/A0 $0.01 2/15/202337,500 shares $618.75 +24.6%N/A0 $0.02 1/31/202330,100 shares $231.77 +0.3%N/A0 $0.01 1/15/202330,000 shares $261.36 -84.2%N/A0 $0.01 12/30/2022189,900 shares $1,955.97 +21.2%N/A0.1 $0.01 12/15/2022156,700 shares $2,138.96 +2,468.9%N/A0.2 $0.01 11/30/20226,100 shares $109.80 No ChangeN/A0 $0.02 10/31/202282,900 shares $1,575.10 +246.9%N/A0.1 $0.02 10/15/202223,900 shares $334.60 +3.9%N/A0 $0.01 9/30/202223,000 shares $402.50 -64.2%N/A0 $0.02 9/15/202264,300 shares $1,543.20 +40.1%N/A0 $0.02 8/31/202245,900 shares $1,331.10 +50.0%N/A0 $0.03 8/15/202230,600 shares $1,025.10 -90.3%N/A0 $0.03 7/31/2022316,400 shares $31,576.72 +316,300.0%N/A0.2 $0.10 7/15/2022100 shares $4.95 -99.5%N/A0 $0.05 6/30/202219,200 shares $979.20 -16.2%N/A0 $0.05 6/15/202222,900 shares $1,809.10 -9.5%N/A0 $0.08 5/31/202225,300 shares $2,757.70 -48.9%N/A0 $0.11 5/15/202249,500 shares $5,445.00 +1,275.0%N/A0.1 $0.11 4/30/20223,600 shares $1,116.00 -91.6%N/A0 $0.31 4/15/202242,600 shares $9,576.48 +17.0%N/A0.2 $0.22 3/31/202236,400 shares $9,209.20 +39.5%N/A0.2 $0.25 3/15/202226,100 shares $6,387.98 +31.8%N/A0.2 $0.24 2/28/202219,800 shares $6,176.61 -5.7%N/A0.1 $0.31 2/15/202221,000 shares $8,400.00 +8.8%N/A0.3 $0.40 1/31/202219,300 shares $9,331.55 No ChangeN/A0.7 $0.48 1/15/202219,300 shares $9,312.25 -15.4%N/A0.8 $0.48 12/31/202122,800 shares $9,804.00 +35.7%N/A0.1 $0.43 12/15/202116,800 shares $5,796.00 No ChangeN/A0.1 $0.35 11/30/202116,800 shares $7,596.96 +9.8%N/A0.3 $0.45 11/15/202115,300 shares $7,497.00 -33.8%N/A0.2 $0.49 10/29/202123,100 shares $11,088.00 +54.0%N/A0.1 $0.48 10/15/202115,000 shares $8,997.00 -56.3%N/A0.1 $0.60 9/30/202134,300 shares $25,546.64 +48.5%N/A0.3 $0.74Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. QBIO Short Interest - Frequently Asked Questions What is Q BioMed's current short interest? Short interest is the volume of Q BioMed shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 8,100 shares of QBIO short. Learn More on Q BioMed's current short interest. Is Q BioMed's short interest increasing or decreasing? Q BioMed saw a increase in short interest in June. As of June 30th, there was short interest totaling 8,100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Q BioMed's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Q BioMed: Amarantus BioScience Holdings, Inc. (0.00%), Oncology Pharma Inc. (0.03%), RenovaCare, Inc. (0.00%), Bruush Oral Care Inc. (77.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($3.35 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.80 billion), Coinbase Global, Inc. ($2.58 billion), Royal Caribbean Cruises Ltd. ($2.17 billion), Moderna, Inc. ($2.13 billion), T. Rowe Price Group, Inc. ($2.11 billion), Palantir Technologies Inc. ($2.03 billion), Extra Space Storage Inc. ($1.81 billion), and Verisk Analytics, Inc. ($1.63 billion). View all of the most shorted stocks. What does it mean to sell short Q BioMed stock? Short selling QBIO is an investing strategy that aims to generate trading profit from Q BioMed as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Q BioMed? A short squeeze for Q BioMed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QBIO, which in turn drives the price of the stock up even further. How often is Q BioMed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QBIO, twice per month. The most recent reporting period available is June, 30 2023. More Short Interest Resources from MarketBeat Related Companies: Amarantus BioScience Short Interest Oncology Pharma Short Interest RenovaCare Short Interest Bruush Oral Care Short Interest Abliva AB (publ) Short Interest Affymax Short Interest American Bio Medica Short Interest Anthera Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:QBIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets